Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

An assessment of essential considerations for clinicians adopting new DVT tools, focusing on efficacy, safety, and ...

Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

MBG and STR were significantly improved in the thrombus aspiration group. In addition, manual thrombectomy was associated with a lower incidence of cardiac death and nonfatal re-infarction at 1 year.

For stroke patients undergoing mechanical thrombectomy, adjunctive intra-arterial thrombolytics fell short for further ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

“This trial is a key step toward delivering a more streamlined, efficient, and precise thrombectomy solution ... directional aspiration, and the elimination of multiple dilator or wire exchanges ...